CGS 15943
Tocris Bioscience | Catalog # 1699
Key Product Details
Description
Product Description
CGS 15943 is a potent adenosine receptor antagonist (Ki values are 3.5, 4.2, 16 and 51 nM for human A1, A2A, A2B and A3 receptors respectively). Inhibits the catalytic subunit of the class IB PI3K isoform p110γ (IC50 = 1.1 μM). Blocks HCC and HDAC cell proliferation in vitro via inhibition of the PI3K/Akt pathway; reduces proliferation of ER+ breast cancer cells. Also acts as a BMP-4 mimetic to stimulate osteogenic differentiation. Orally active in vivo.
Product Specifications for CGS 15943
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 1.43 | 5 |
Preparing Stock Solutions for CGS 15943
The following data is based on the product molecular weight 285.69.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.05 mM | 70.01 mL | 350.03 mL | 700.06 mL |
| 0.25 mM | 14.00 mL | 70.01 mL | 140.01 mL |
| 0.5 mM | 7.00 mL | 35.00 mL | 70.01 mL |
| 2.5 mM | 1.40 mL | 7.00 mL | 14.00 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 66 publications citing the usage of this product.
- Edling Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway. Cancer Biol.Ther. 2014 PMID: 24521981
- Shropshire Association of adenosine signaling gene signature with estrogen receptor-positive breast and prostate cancer bone metastasis. Front.Med. (Lausanne) 2022 PMID: 36186774
- Wesseler Phenotypic discovery of triazolo[1,5-c]quinazolines as a first-in-class bone morphogenetic protein amplifier chemotype. J.Med.Chem. 2022 PMID: 36346705
- Williams Biochemical characterization of the triazoloquinazoline CGS 15943, a novel, non-xanthine adenosine antagonist. J.Pharmacol.Exp.Ther. 1987 PMID: 2883298
- Klotz Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch.Pharmacol. 2000 PMID: 11111832
- Ghai Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist. J.Pharmacol.Exp.Ther. 1987 PMID: 3656113
Product Documents for CGS 15943
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for CGS 15943
For research use only
Citations for CGS 15943
Customer Reviews for CGS 15943 (1)
Have you used CGS 15943?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
-
Species: MouseAssay Type: In VivoCell Line/Tissue: systemicVerified Customer | Posted 01/05/2018Drug was dissolved using saline + 0.3% tween 80. (Vortexed for 1 minute and sonicated for 5 min) X3 times.This compound was used both in vivo and in vitro. For in vivo experiments we injected the compound systemically into transgenic mice and evaluated the effect of the drug on motor behavior. In vitro we used the drug on slices to evaluate the effect on the physiology of cells.
There are no reviews that match your criteria.